Side effects and watch-outs
- Headache
- Nausea
- Abdominal pain
- Diarrhoea
- Relatively well tolerated in Phase 2 trials
- Not recommended in pregnancy
Peptide / Gut & Repair
Larazotide Acetate
Tight junction regulator reducing intestinal permeability (leaky gut). Most studied for coeliac disease. Oral administration — poorly absorbed systemically (intentional). Failed FDA Phase 3 but widely used in research.
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.